Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus

NCT00003316 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

NETWORK

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: gemcitabine hydrochloride

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]